Hubungan Kadar Hepcidin dan Soluble Transferrin Receptor (sTfR)
DAFTAR PUSTAKA
1. Cappelini MD, Cohen A, Eleftheriou A, Piga A, Porter J, Taher A, :
Thalassemia International Federation; 2008, 2nd ed. Cyprus, 2010
2. Weatherall, DJ. The Thalassemias. Williams hematology. 6th edition.
Mc-Graw Hill,November 2000.2
3. Weatherall,
DJ,
Clegg
Jb.
Thalassemia
Syndromes.
4rd
edition.Blackwell science.UK.2001
4. Pignatti CB, Galanello R.Thalassemias and Related disorders:
Quantitative Disorderd of
Hemoglobin Synthesis. In: Wintrobe’s
Clinical Hematology. Lipincot Williams & Wilkins. Philadelphia.2009;C
39:p.1084-1130
5. Cavalli-Sforza, L.L.,Menozzi, P . and Piazza A.1994. The History and
Geography of Human Genes. Princeton University Press.
Princeton, New Jersey. 2: 60-121
6. I Wahidiyat, PA Wahidiyat. Genetic problems at present and their
challenges in future: Thalassemia as a model [serial online] 2006 [cited
2010 Nov 22] Available from: Pediatrica Indonesia
7. Ganie RA. Studi DNA thalassemia α° Southeast Asian type di Medan
[Disertasi Doktor bidang Ilmu Kedokteran Universitas Sumatera Utara].
Medan: Universitas Sumatera Utara; 2003.
Universitas Sumatera Utara
8. Langlois S, Ford JC, Chitayat D. Carrier Screening for Thalassemia
and Hemoglobinopathies in canada. Joint SOGC-CCMG Clinical
Practice Guidline 2008, 218: 950-959
9. Lanni
F.
Heterogenitas
molekular
Genaglobin-β
di
Indonesia,
kaitannya dengan pola penyebaran thalassemia-β serta afinitas
genetik antar populasi di Indonesia [Disertasi Doktor bidang Ilmu
Kedokteran Universitas Gajah Mada]. Yogyakarta: Universitas Gajah
Mada; 2002.
10. World Health Organization/Thalassemia International Federation.
Prosiding dari: Joint meeting on the prevention and control of
haemoglobinopathies.
Nicosia-cyprus:
World
Health
Organization/Thalassemia International Federation, 1994:20
11. Eleftheriou A. What is the thalassemia. Thalassaemia International
Federation. Nicosia-Cyprus, 2003.
12. Taher A, Vichnsky E, Musallam K, Domenica M, Cappellini, Viprakasit
V, Guideline For The Management Of Non Transfusion Dependent
Thalassemia (NTDT)
13. Nemeth E. Hepcidin in Β Thalassemia [serial online]. 2010 [ cited 2010
Jul 23] . Available from : Gene Review.
14. Nemeth, E Targetting the Hepcidin-Ferroportin Axis in the Diagnosis
and Treatment of Anemias 2010. Advances in Hemtology
15. Zimmermann M.B, dkk. Iron metabolism in heterozygotes for
hemoglobin E (HbE), alpha-thalassemia 1, or b-thalassemia and in
Universitas Sumatera Utara
coumpound heterozygotes for HbE/b-thalassemia. American Journal of
Clinical Nutrition
16. Galanello R and Origa R. Beta-Thalassemia. Orphanet Journal Of
Rare Diseases 2010.
17. Kattamis A,dkk. The effects of rytropoetic activity and iron burden on
hepcidin expression in patients with thalassemia major.2006 [cited
2011 agt 3].
18. Rachmilewitz EA, and Giardina PJ. How I Treat Thalassemia, in:How I
Treat. Blood, 2011;3479-3488.
19. Collins, F.S. and Weissman, S.M. 1984. “The Molecular Genetics of
Human Hemoglobin “ .Prog. Nucleic Acid Res. Mol.Biol. 31:315
20. Galanello R and Origa R. Beta-Thalassemia. Orphanet Journal Of
Rare Diseases 2010.
21. Srivorakun H, Fucharoen G, Changtrakul Y, Komwilaisak P, n
Fucharoen S. Thalassemia and hemoglobinopathies in Southeast
22. Wirawan R. Analisa Hemoglobin dengan cara konvensional dan
mikrokapiler elektroforesis. Jakarta. Balai Penerbit FKUI, 2011;h.78.
23. Bain BJ. Haemoglobin and the genetic of haemoglobin synthesis, in:
Haemoglobinopathy. Second Edition. Blackwell Publishing. 2006;p.125
24. Bernard G.Forget and Ross C.Hardison. The Normal Structure and
Regulation of Human Globin Gene Cluster, in: Disorders of
Universitas Sumatera Utara
Hemoglobin. Genetics, Pathophysiology, and Clinical. Cambridge
University Press. New York. 2009;p.46-61
25. About
Alpha
Thalassemia.
In:
Hemoglobin
Disorders
Hemoglobinopathies. Thalassemia International Federation. 2007.
26. Ghodekar SR, Gramurohit ND, Kadam SS, and Thorat RM.
Thalassemia: A Review. International Journal of Pharma research and
Development-Online (IJPRD).2010.
27. Dimitris L,Leukopoulos. Haemoglobinophaties. Macmillan Plubisher
Ltd. 2002.
28. Weatherall DJ. Fortnightly review: The Thalassemia. BMJ, 1977;
Ltd.2002
29. Dessypris EN, Sawyer ST. Erythropoiesis. In: Wintrobes’s Clinical
Hematology, 12nd ed. Lippincot Williams & Wilkins Philadelphia 2009:
107
30. Wickrema A, Kee B. Molecular Basis of Hematopoiesis. Springer
Science New York 2009 : 74
31. Andrews NC. Iron Deficiency and Relared Disorders. In : Wintrobe’s
Clinical Hematology, 12nd ed. Lippincot Williams & Wilkins Philadelphia
2009 : 815
32. Hoffbrand
AV,
Catovsky
D,
Tuddenham
EGD.
Postgraduate
Hematology 5th ed. Blackwell Publishing Ltd Massachusetts 2005 : 2425, 89-91
Universitas Sumatera Utara
33. Srivorakun H, Fucharoen G, Changtrakul Y, Komwilaisak P, n
Fucharoen S. Thalassemia and hemoglobinopathies in Southeast
Asian
newborns:
diagnostic
assessment
using
capillary
electrophoresis system. Clinical Biochemistry. Published by Elsevier
Inc. 2011; 406-411.
34. John M,Old. DNA Diagnosis of Hemoglobin Mutations. In:Hemoglobin
Disorde
Molecular
and
Protocols.
Humana
Press
Inc.
Totowa,NJ,2003,Vol 82; 101-108.
35. Elizabeth G. Genotype-phenotype Diversity of Beta-Thalassemia in
malaysia: Treatment Options and Emerging Therapies.
36. Bain BJ. The α, β, δ dan γ Thalassaemias and related conditions, in:
Hemoglobinopathy. Second Edition. Blackwell Publishing.2006;p:63138
37. Rozenberg
G.
Haemoglobin
Disrorders,
in:
Microscopic
3e
Haematology a Practical Guide for The Laboratory. Elsevier. Australia.
2011;p:23-33
38. Rund D and Rachmilewitz E. Β-thalassemia. N ENGL J MED, 353;11
39. Chui DH, Cunningham MJ, Lou Hy, Wolf LC, Neufeld EJ, and
Steinberg MH. Screening and counseling for Thalassemia. Blood
2006;vol 107.Number 4
40. Long X, Fang J, Yao L, Xiao Q, Pan T. Correlation Analysis between
Mean Corpuscular Hemoglobin and Mean Corpuscular Volume for
Thalassemia Screening in Large Population. American Journal of
Analytical Chemistry, 2014,5,901-907
Universitas Sumatera Utara
41. Eleftheriou A. What is the thalassemia . Thalassemia International
Federation. Nicosia-Crprus, 2003
42. Pignatti CB, Galanello R. Thalassemia and related disorders:
quantitative disorders of hemoglobin synthesis. Dalam: Greer JP,
Foerster J, Rodgers GM, et al., editors. Wintrobe’s clinical hematology.
12nd ed. Philadelphia: Lippincott Williams & Wilkins; 2009. p.10831098
43. Mosca A, Paleari R, Ivaldi G, Galanello R, dan Giordano PC. The role
of haemoglobin A2 testing in the diagnosis of thalassaemias and
related haemoglobinopathies. J Clin Pathol 2009;62:13–17.
44. Mais DD, Gulbranson RD, and Keren DF. The Range of Hemoglobin
A2 in hemoglobin E Heterozygotes as Determined by Capillary
Electrophoresis. Am J Clin Pathol 2009;132:34-38.
45. Pardede, D.K.B.2013. Hepcidin : Perannya dalam pathogenesis dan
implikasinya terhadap tatalaksana anemia pada penyakit kronis.
46. Krause, A., S. Neitz, H.J.Magert. et al, 2000. LEAP-1 , a novel highly
disulfide – bonded human peptide, exhibits antimicrobial activity, FEBS
Lett, 480:147-150
47. Ganz, T.2003. Hepcidin , a key regulator of iron metabolism and
mediator of anemia of inflammation. Blood, 20014
48. Perdana Y W, Jacobus J D. Hepcidin dan Anemia Defisiensi Besi
49. Jones, E.,Pasricha,S.R.,et al. Hepcidin is suppressed by erytroiesis in
hemoglobin E β-thalassemia and β-thalassemia trait.Blood. 2015
Universitas Sumatera Utara
50. Testa U. Protein of Iron metabolism. Florida: CRC Press; 2002. p.143382.
51. Biovendor Research and Diagnostic product. Version 57 030412 15
52. Worwood M, May A. Iron Deficiency Anemia and Iron Overload. In
Dacie & Lewis Practical Hematology 11th ed. Elsevier Churchill
Livingstone 2011:190
53. Atmakusuma D. Thalassemia: Manifestasi Klinis , Pendekatan
diagnosis, dan Thalassemia Intermedia. Dalam: Ilmu Penyakit Dalam.
Internal Publishing. Jilid II, Edisi V, Bab 220; 1387-1405.
54. Fucharoen
S,
Winichagoon
P.in:
New
updating
into
hemoglobinopathies. International Journal of laboratory Hematology.
Blackwell Publishing Ltd. 2012:559-565.
55. Giordano PC. Strategies for basic laboratory diagnostics of the
hemoglobinopathies in multi-ethnic societies: interpretation of results
and pitfalls. International Journal of laboratory Hematology. Blackwell
Publishing Ltd. 2012; 1-15.
56. Macdougall, I.C., J. Malyazko, R.C.Hider, and S.S. Bansal. 2010.
Current Status of theMeasurement of Blodd Hepcidin level in Chronic
Kidney Disease. Clin J Am Soc neprol, 5: 1681-1689
57. Bain.J.B, Bates.I, Laffan.A.M, Lewis.S.M, Dacie and Lewis Practical
Haematology: Eleventh Edition181-190
58. D’Angelo Guide, Role of Hepcidin in The Patofisiology and Diagnosis
of Anemia, Blood Research, 2013; volume 48, no: 1
Universitas Sumatera Utara
1. Cappelini MD, Cohen A, Eleftheriou A, Piga A, Porter J, Taher A, :
Thalassemia International Federation; 2008, 2nd ed. Cyprus, 2010
2. Weatherall, DJ. The Thalassemias. Williams hematology. 6th edition.
Mc-Graw Hill,November 2000.2
3. Weatherall,
DJ,
Clegg
Jb.
Thalassemia
Syndromes.
4rd
edition.Blackwell science.UK.2001
4. Pignatti CB, Galanello R.Thalassemias and Related disorders:
Quantitative Disorderd of
Hemoglobin Synthesis. In: Wintrobe’s
Clinical Hematology. Lipincot Williams & Wilkins. Philadelphia.2009;C
39:p.1084-1130
5. Cavalli-Sforza, L.L.,Menozzi, P . and Piazza A.1994. The History and
Geography of Human Genes. Princeton University Press.
Princeton, New Jersey. 2: 60-121
6. I Wahidiyat, PA Wahidiyat. Genetic problems at present and their
challenges in future: Thalassemia as a model [serial online] 2006 [cited
2010 Nov 22] Available from: Pediatrica Indonesia
7. Ganie RA. Studi DNA thalassemia α° Southeast Asian type di Medan
[Disertasi Doktor bidang Ilmu Kedokteran Universitas Sumatera Utara].
Medan: Universitas Sumatera Utara; 2003.
Universitas Sumatera Utara
8. Langlois S, Ford JC, Chitayat D. Carrier Screening for Thalassemia
and Hemoglobinopathies in canada. Joint SOGC-CCMG Clinical
Practice Guidline 2008, 218: 950-959
9. Lanni
F.
Heterogenitas
molekular
Genaglobin-β
di
Indonesia,
kaitannya dengan pola penyebaran thalassemia-β serta afinitas
genetik antar populasi di Indonesia [Disertasi Doktor bidang Ilmu
Kedokteran Universitas Gajah Mada]. Yogyakarta: Universitas Gajah
Mada; 2002.
10. World Health Organization/Thalassemia International Federation.
Prosiding dari: Joint meeting on the prevention and control of
haemoglobinopathies.
Nicosia-cyprus:
World
Health
Organization/Thalassemia International Federation, 1994:20
11. Eleftheriou A. What is the thalassemia. Thalassaemia International
Federation. Nicosia-Cyprus, 2003.
12. Taher A, Vichnsky E, Musallam K, Domenica M, Cappellini, Viprakasit
V, Guideline For The Management Of Non Transfusion Dependent
Thalassemia (NTDT)
13. Nemeth E. Hepcidin in Β Thalassemia [serial online]. 2010 [ cited 2010
Jul 23] . Available from : Gene Review.
14. Nemeth, E Targetting the Hepcidin-Ferroportin Axis in the Diagnosis
and Treatment of Anemias 2010. Advances in Hemtology
15. Zimmermann M.B, dkk. Iron metabolism in heterozygotes for
hemoglobin E (HbE), alpha-thalassemia 1, or b-thalassemia and in
Universitas Sumatera Utara
coumpound heterozygotes for HbE/b-thalassemia. American Journal of
Clinical Nutrition
16. Galanello R and Origa R. Beta-Thalassemia. Orphanet Journal Of
Rare Diseases 2010.
17. Kattamis A,dkk. The effects of rytropoetic activity and iron burden on
hepcidin expression in patients with thalassemia major.2006 [cited
2011 agt 3].
18. Rachmilewitz EA, and Giardina PJ. How I Treat Thalassemia, in:How I
Treat. Blood, 2011;3479-3488.
19. Collins, F.S. and Weissman, S.M. 1984. “The Molecular Genetics of
Human Hemoglobin “ .Prog. Nucleic Acid Res. Mol.Biol. 31:315
20. Galanello R and Origa R. Beta-Thalassemia. Orphanet Journal Of
Rare Diseases 2010.
21. Srivorakun H, Fucharoen G, Changtrakul Y, Komwilaisak P, n
Fucharoen S. Thalassemia and hemoglobinopathies in Southeast
22. Wirawan R. Analisa Hemoglobin dengan cara konvensional dan
mikrokapiler elektroforesis. Jakarta. Balai Penerbit FKUI, 2011;h.78.
23. Bain BJ. Haemoglobin and the genetic of haemoglobin synthesis, in:
Haemoglobinopathy. Second Edition. Blackwell Publishing. 2006;p.125
24. Bernard G.Forget and Ross C.Hardison. The Normal Structure and
Regulation of Human Globin Gene Cluster, in: Disorders of
Universitas Sumatera Utara
Hemoglobin. Genetics, Pathophysiology, and Clinical. Cambridge
University Press. New York. 2009;p.46-61
25. About
Alpha
Thalassemia.
In:
Hemoglobin
Disorders
Hemoglobinopathies. Thalassemia International Federation. 2007.
26. Ghodekar SR, Gramurohit ND, Kadam SS, and Thorat RM.
Thalassemia: A Review. International Journal of Pharma research and
Development-Online (IJPRD).2010.
27. Dimitris L,Leukopoulos. Haemoglobinophaties. Macmillan Plubisher
Ltd. 2002.
28. Weatherall DJ. Fortnightly review: The Thalassemia. BMJ, 1977;
Ltd.2002
29. Dessypris EN, Sawyer ST. Erythropoiesis. In: Wintrobes’s Clinical
Hematology, 12nd ed. Lippincot Williams & Wilkins Philadelphia 2009:
107
30. Wickrema A, Kee B. Molecular Basis of Hematopoiesis. Springer
Science New York 2009 : 74
31. Andrews NC. Iron Deficiency and Relared Disorders. In : Wintrobe’s
Clinical Hematology, 12nd ed. Lippincot Williams & Wilkins Philadelphia
2009 : 815
32. Hoffbrand
AV,
Catovsky
D,
Tuddenham
EGD.
Postgraduate
Hematology 5th ed. Blackwell Publishing Ltd Massachusetts 2005 : 2425, 89-91
Universitas Sumatera Utara
33. Srivorakun H, Fucharoen G, Changtrakul Y, Komwilaisak P, n
Fucharoen S. Thalassemia and hemoglobinopathies in Southeast
Asian
newborns:
diagnostic
assessment
using
capillary
electrophoresis system. Clinical Biochemistry. Published by Elsevier
Inc. 2011; 406-411.
34. John M,Old. DNA Diagnosis of Hemoglobin Mutations. In:Hemoglobin
Disorde
Molecular
and
Protocols.
Humana
Press
Inc.
Totowa,NJ,2003,Vol 82; 101-108.
35. Elizabeth G. Genotype-phenotype Diversity of Beta-Thalassemia in
malaysia: Treatment Options and Emerging Therapies.
36. Bain BJ. The α, β, δ dan γ Thalassaemias and related conditions, in:
Hemoglobinopathy. Second Edition. Blackwell Publishing.2006;p:63138
37. Rozenberg
G.
Haemoglobin
Disrorders,
in:
Microscopic
3e
Haematology a Practical Guide for The Laboratory. Elsevier. Australia.
2011;p:23-33
38. Rund D and Rachmilewitz E. Β-thalassemia. N ENGL J MED, 353;11
39. Chui DH, Cunningham MJ, Lou Hy, Wolf LC, Neufeld EJ, and
Steinberg MH. Screening and counseling for Thalassemia. Blood
2006;vol 107.Number 4
40. Long X, Fang J, Yao L, Xiao Q, Pan T. Correlation Analysis between
Mean Corpuscular Hemoglobin and Mean Corpuscular Volume for
Thalassemia Screening in Large Population. American Journal of
Analytical Chemistry, 2014,5,901-907
Universitas Sumatera Utara
41. Eleftheriou A. What is the thalassemia . Thalassemia International
Federation. Nicosia-Crprus, 2003
42. Pignatti CB, Galanello R. Thalassemia and related disorders:
quantitative disorders of hemoglobin synthesis. Dalam: Greer JP,
Foerster J, Rodgers GM, et al., editors. Wintrobe’s clinical hematology.
12nd ed. Philadelphia: Lippincott Williams & Wilkins; 2009. p.10831098
43. Mosca A, Paleari R, Ivaldi G, Galanello R, dan Giordano PC. The role
of haemoglobin A2 testing in the diagnosis of thalassaemias and
related haemoglobinopathies. J Clin Pathol 2009;62:13–17.
44. Mais DD, Gulbranson RD, and Keren DF. The Range of Hemoglobin
A2 in hemoglobin E Heterozygotes as Determined by Capillary
Electrophoresis. Am J Clin Pathol 2009;132:34-38.
45. Pardede, D.K.B.2013. Hepcidin : Perannya dalam pathogenesis dan
implikasinya terhadap tatalaksana anemia pada penyakit kronis.
46. Krause, A., S. Neitz, H.J.Magert. et al, 2000. LEAP-1 , a novel highly
disulfide – bonded human peptide, exhibits antimicrobial activity, FEBS
Lett, 480:147-150
47. Ganz, T.2003. Hepcidin , a key regulator of iron metabolism and
mediator of anemia of inflammation. Blood, 20014
48. Perdana Y W, Jacobus J D. Hepcidin dan Anemia Defisiensi Besi
49. Jones, E.,Pasricha,S.R.,et al. Hepcidin is suppressed by erytroiesis in
hemoglobin E β-thalassemia and β-thalassemia trait.Blood. 2015
Universitas Sumatera Utara
50. Testa U. Protein of Iron metabolism. Florida: CRC Press; 2002. p.143382.
51. Biovendor Research and Diagnostic product. Version 57 030412 15
52. Worwood M, May A. Iron Deficiency Anemia and Iron Overload. In
Dacie & Lewis Practical Hematology 11th ed. Elsevier Churchill
Livingstone 2011:190
53. Atmakusuma D. Thalassemia: Manifestasi Klinis , Pendekatan
diagnosis, dan Thalassemia Intermedia. Dalam: Ilmu Penyakit Dalam.
Internal Publishing. Jilid II, Edisi V, Bab 220; 1387-1405.
54. Fucharoen
S,
Winichagoon
P.in:
New
updating
into
hemoglobinopathies. International Journal of laboratory Hematology.
Blackwell Publishing Ltd. 2012:559-565.
55. Giordano PC. Strategies for basic laboratory diagnostics of the
hemoglobinopathies in multi-ethnic societies: interpretation of results
and pitfalls. International Journal of laboratory Hematology. Blackwell
Publishing Ltd. 2012; 1-15.
56. Macdougall, I.C., J. Malyazko, R.C.Hider, and S.S. Bansal. 2010.
Current Status of theMeasurement of Blodd Hepcidin level in Chronic
Kidney Disease. Clin J Am Soc neprol, 5: 1681-1689
57. Bain.J.B, Bates.I, Laffan.A.M, Lewis.S.M, Dacie and Lewis Practical
Haematology: Eleventh Edition181-190
58. D’Angelo Guide, Role of Hepcidin in The Patofisiology and Diagnosis
of Anemia, Blood Research, 2013; volume 48, no: 1
Universitas Sumatera Utara